Richard Schilsky to Phenylurea Compounds
This is a "connection" page, showing publications Richard Schilsky has written about Phenylurea Compounds.
Connection Strength
0.934
-
Regorafenib in Patients With Solid Tumors With BRAF Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. JCO Precis Oncol. 2024 Apr; 8:e2300527.
Score: 0.934